Curated News: National Institutes of Health (NIH)

Filters close
Newswise: Study Gives Insight Into Cause of Severe Inflammatory Bowel Disease
Released: 20-Apr-2023 12:15 PM EDT
Study Gives Insight Into Cause of Severe Inflammatory Bowel Disease
Cedars-Sinai

Cedars-Sinai investigators have identified a genetic variant that increases people’s risk of developing perianal Crohn’s disease, the most debilitating manifestation of Crohn’s disease.

Released: 20-Apr-2023 11:05 AM EDT
A New Method to Test Cancer Drug Toxicity
Tufts University

A new study from researchers at Cummings School of Veterinary Medicine at Tufts University and Tufts Medical Center reports that heart tissue obtained through organ donations from dogs dying of other causes are a promising platform for testing cancer drug toxicity, offering scientists a new alternative.

Newswise: New Lung Immuno-oncology Therapeutic Strategy Identified
19-Apr-2023 2:50 PM EDT
New Lung Immuno-oncology Therapeutic Strategy Identified
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated in a preclinical study a potential new therapeutic approach to treating the most common form of lung cancer. The strategy involves inhibiting the immune-system molecule TREM2 while enhancing natural killer cells (the so-called protectors of the immune system). It was described in the April 20 online issue of Nature Immunology.

Released: 20-Apr-2023 10:00 AM EDT
ASBMB cautions against sacrificing science funds to make debt-ceiling deal
American Society for Biochemistry and Molecular Biology (ASBMB)

ASBMB emphasizes the importance of preserving research from scientists supported by the NIH, NSF and DOE during debt-ceiling deal

   
Newswise: Healing the unhealable: New approach helps bones mend themselves
Released: 19-Apr-2023 4:30 PM EDT
Healing the unhealable: New approach helps bones mend themselves
University of Pittsburgh

University of Pittsburgh researchers developed a novel approach that promoted bone regeneration in mice without implantation of bone tissue or biomaterials.

   
14-Apr-2023 4:20 PM EDT
Simple Test May Predict Cognitive Impairment Long Before Symptoms Appear
American Academy of Neurology (AAN)

In people with no thinking and memory problems, a simple test may predict the risk of developing cognitive impairment years later, according to a study published in the April 19, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: NIH Trial Evaluating Mpox Vaccine in Adolescents
Released: 19-Apr-2023 9:30 AM EDT
NIH Trial Evaluating Mpox Vaccine in Adolescents
George Washington University

The National Institutes of Health trial to evaluate the mpox (previously known as monkeypox) vaccine JYNNEOS has now entered the next stage and is studying the immune responses to and the safety of the vaccine in adolescents. The George Washington University is one of 18 clinical trial sites across the United States that have launched this stage testing the JYNNEOS vaccine.

Released: 18-Apr-2023 8:30 PM EDT
School prevalence of stimulant therapy for ADHD associated with higher rates of prescription stimulant misuse among teens
NIH National Institute on Drug Abuse (NIDA)

Researchers have identified a strong association between prevalence of prescription stimulant therapy for attention-deficit/hyperactivity disorder (ADHD) and rates of prescription stimulant misuse (taken in a way other than as directed by a clinician) by students in middle and high schools.

Newswise: Study suggests longer time between COVID-19 vaccines more effective for some
Released: 18-Apr-2023 7:20 PM EDT
Study suggests longer time between COVID-19 vaccines more effective for some
Houston Methodist

A recent Houston Methodist study may offer some guidance on when certain populations should get their next booster. A research team of computational medicine and data scientists from the Houston Methodist Research Institute predicted the immune response to COVID-19 vaccines with a math model they developed, and also found that current CDC dosing intervals may require customization to protect all individuals alike.

Newswise: Menu Calorie Labels Estimated to Save U.S. Billions on Cancer Care
14-Apr-2023 1:40 PM EDT
Menu Calorie Labels Estimated to Save U.S. Billions on Cancer Care
Tufts University

Modeling study estimates menu calorie labelling may prevent at least 28,000 obesity-associated cancer cases and 16,700 cancer deaths over a lifetime, saving a combined $2.8 billion in net healthcare and societal costs.

Newswise: Study: Vitamin D May Play a Role in Prostate Cancer Disparities
Released: 18-Apr-2023 12:00 PM EDT
Study: Vitamin D May Play a Role in Prostate Cancer Disparities
Cedars-Sinai

Vitamin D deficiency could be the reason African American men experience more aggressive prostate cancer at a younger age compared with European American men, new research from Cedars-Sinai Cancer suggests.

14-Apr-2023 11:00 AM EDT
In some US schools, 1 in 4 students report misusing prescription stimulants
University of Michigan

U.S. middle and high schools with the most students taking prescription stimulants to treat ADHD also had, overall, the highest percentage of students who misused prescription stimulants within the past year.

Released: 18-Apr-2023 10:15 AM EDT
Why Do Children Develop Type 2 Diabetes? $4.1 Million NIH Grant Will Help Montefiore Einstein Researchers Investigate
Albert Einstein College of Medicine

Type 2 diabetes (T2D) is surging among U.S. children. The number of youths under age 20 living with the disease has nearly doubled between 2001 and 2017, and yet—aside from increases in childhood obesity—the reasons for this disturbing increase are not clear. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), has awarded the Children’s Hospital at Montefiore (CHAM) and Albert Einstein College of Medicine a six-year, $4.1 million grant to identify the biological and social factors that cause children and adolescents to develop the condition.

Newswise: Researchers discover how some brain cells transfer material to neurons in mice
Released: 17-Apr-2023 3:35 PM EDT
Researchers discover how some brain cells transfer material to neurons in mice
UC Davis Health

A UC Davis study is the first to report on a material transfer mechanism from cells, known as oligodendrocytes, to neurons in the brain of a mouse model. This discovery opens new possibilities for understanding brain maturation and finding treatments for many neurological conditions.

   
12-Apr-2023 3:05 PM EDT
Two brain networks are activated while reading, study finds
University of Texas Health Science Center at Houston

When a person reads a sentence, two distinct networks in the brain are activated, working together to integrate the meanings of the individual words to obtain more complex, higher-order meaning, according to a study at UTHealth Houston.

Newswise: AACR: Mutations in three key genes associated with poor outcomes in lung cancer patients treated with KRAS G12C inhibitors
13-Apr-2023 3:35 PM EDT
AACR: Mutations in three key genes associated with poor outcomes in lung cancer patients treated with KRAS G12C inhibitors
University of Texas MD Anderson Cancer Center

A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered that co-occurring mutations in three tumor suppressor genes – KEAP1, SMARCA4 and CDKN2A – are linked with poor clinical outcomes in patients with KRAS G12C-mutant non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitors adagrasib or sotorasib.

Released: 17-Apr-2023 11:05 AM EDT
Leaps in artificial blood research aim to improve product safety, efficacy
Ohio State University

Researchers have made huge strides in ensuring that red blood cell substitutes – or artificial blood – are able to work safely and effectively when transfused into the bloodstream.

Released: 17-Apr-2023 10:55 AM EDT
New genetic target for male contraception identified
Washington State University

Discovery of a gene in multiple mammalian species could pave the way for a highly effective, reversible and non-hormonal male contraceptive for humans and animals.

Released: 14-Apr-2023 3:25 PM EDT
Wayne State researcher receives $1.95 million NIH grant to study impact of inositol homeostasis on essential cellular functions
Wayne State University Division of Research

A researcher from Wayne State University’s Department of Biological Sciences has received a five-year, $1.95 million grant from the National Institute of General Medical Sciences of the National Institutes of Health to identify mechanisms that regulate inositol synthesis in mammalian cells and determine the cellular consequences of inositol depletion.

   
Released: 13-Apr-2023 7:35 PM EDT
The potential and challenges of mucosal COVID-19 vaccines
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop have now been published as a report in npj Vaccines.

Newswise: Eye-opening Origin Story: Scientists Trace Key Innovation in Our Camera-like Vision to Bacteria
Released: 13-Apr-2023 3:25 PM EDT
Eye-opening Origin Story: Scientists Trace Key Innovation in Our Camera-like Vision to Bacteria
University of California San Diego

Scientists have traced the origin of a unique protein key to vertebrate’s camera-like vision back 500 million years. Their analysis of more than 900 genomes across the tree of life revealed that the protein came through horizontal gene transfer from foreign bacterial genes.

Newswise: Implantable device shrinks pancreatic tumors
Released: 13-Apr-2023 2:35 PM EDT
Implantable device shrinks pancreatic tumors
Houston Methodist

Houston Methodist nanomedicine researchers have found a way to tame pancreatic cancer - one of the most aggressive and difficult to treat cancers - by delivering immunotherapy directly into the tumor with a device that is smaller than a grain of rice.

   
Released: 13-Apr-2023 9:40 AM EDT
FSU researchers examine role of crucial hormone and exercise with $1.8 million NIH grant
Florida State University

A new, $1.8 million Florida State University study funded by the National Institutes of Health will examine the role adiponectin plays in the circulatory system of aging adults and how exercise affects its influence on vascular health. The research aims to offer more insight into how exercise brings benefits and explore how adiponectin can potentially be used for treatment.

Newswise: Research identifies new target that may prevent blood cancer
Released: 12-Apr-2023 4:50 PM EDT
Research identifies new target that may prevent blood cancer
Vanderbilt University Medical Center

An international coalition of biomedical researchers co-led by Alexander Bick, MD, PhD, at Vanderbilt University Medical Center has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients’ risk of blood cancer. The technique, called PACER, led to the identification of a gene that, when activated, drives clonal expansion.

Newswise: Cancer cells penetrate deep into their environment
Released: 12-Apr-2023 4:20 PM EDT
Cancer cells penetrate deep into their environment
Washington University in St. Louis

New research from the McKelvey School of Engineering at Washington University in St. Louis has found that cancer cells can sense a layer of cells beneath the top collagen layer on which they normally travel, while normal cells cannot.

7-Apr-2023 3:25 PM EDT
Is the Language You Speak Tied to Outcome After Stroke?
American Academy of Neurology (AAN)

Studies have shown that Mexican Americans have worse outcomes after a stroke than non-Hispanic white Americans. A new study looks at whether the language Mexican American people speak is linked to how well they recover after a stroke. The study is published in the April 12, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology

Newswise: AI can spot early signs of Alzheimer’s in speech patterns, study shows
Released: 12-Apr-2023 1:30 PM EDT
AI can spot early signs of Alzheimer’s in speech patterns, study shows
UT Southwestern Medical Center

New technologies that can capture subtle changes in a patient’s voice may help physicians diagnose cognitive impairment and Alzheimer’s disease before symptoms begin to show, according to a UT Southwestern Medical Center researcher who led a study published in the Alzheimer’s Association publication Diagnosis, Assessment & Disease Monitoring.

   
Newswise: Whether Physical Exertion Feels ‘Easy’ or ‘Hard’ May Be Due to Dopamine Levels, Study Suggests
Released: 12-Apr-2023 1:00 PM EDT
Whether Physical Exertion Feels ‘Easy’ or ‘Hard’ May Be Due to Dopamine Levels, Study Suggests
Johns Hopkins Medicine

Dopamine, a brain chemical long associated with pleasure, motivation and reward-seeking, also appears to play an important role in why exercise and other physical efforts feel “easy” to some people and exhausting to others, according to results of a study of people with Parkinson’s disease led by Johns Hopkins Medicine researchers. Parkinson’s disease is marked by a loss of dopamine-producing cells in the brain over time.

Newswise: Cedars-Sinai Cancer Collaborates on a New Type of Clinical Trial
Released: 12-Apr-2023 12:45 PM EDT
Cedars-Sinai Cancer Collaborates on a New Type of Clinical Trial
Cedars-Sinai

Investigators from Cedars-Sinai Cancer are collaborating on a streamlined clinical trial design in a study called Pragmatica-Lung.

Newswise: New Study Flips the Script on Liver Cancer
Released: 12-Apr-2023 11:00 AM EDT
New Study Flips the Script on Liver Cancer
University of California San Diego

UC San Diego scientists find a protein associated with liver cancer may actually be the key to protecting against it. By blocking ferroptosis, a form of liver cell death, the protein prevents liver damage and its progression to cancer.

7-Apr-2023 8:00 AM EDT
Testing vaccine candidates quickly with lab-grown mini-organs
American Chemical Society (ACS)

Researchers reporting in ACS Central Science have developed a new testing platform that encapsulates B cells — some of the most important components of the immune system — into miniature “organoids” to make vaccine screening quicker and greatly reduce the number of animals needed for testing.

   
Newswise: Untangling the Mystery of Sleep
Released: 11-Apr-2023 12:40 PM EDT
Untangling the Mystery of Sleep
Harvard Medical School

Sleep is one of the most essential human activities — so essential, in fact, that if we don’t get enough sleep for even one night, we may struggle to think, react, and otherwise make it through the day. Yet, despite its importance for function and survival, scientists still don’t fully understand how sleep works.

Newswise: VUMC-Led Trial Shows Two Investigational Drugs Are Ineffective for Treating Severe COVID-19
Released: 11-Apr-2023 12:00 PM EDT
VUMC-Led Trial Shows Two Investigational Drugs Are Ineffective for Treating Severe COVID-19
Vanderbilt University Medical Center

A study published April 11 in the Journal of the American Medical Association (JAMA) evaluated two drugs that act on the renin-angiotensin system (RAS) as potential treatments for severe COVID-19. Severe acute respiratory syndrome coronavirus2 (SARS-CoV-2), the virus that causes COVID-19, enters pulmonary and myocardial cells through binding of its spike protein to the human angiotensin-converting enzyme 2 (ACE2). ACE2 is a vital enzyme that controls blood pressure and blood flow to multiple organs, including the lungs, heart and kidneys.

Released: 11-Apr-2023 6:00 AM EDT
Pesquisa descobre que pacientes com diversos tumores em um seio podem não precisar de mastectomia
Mayo Clinic

De acordo com uma pesquisa conduzida pela Aliança para Ensaios Clínicos em Oncologia e o Centro de Câncer da Mayo Clinic, pacientes com diversos tumores em um seio podem ser capazes de evitar uma mastectomia se os tumores puderem ser removidos enquanto uma quantidade suficiente de tecido mamário puder ser preservada.

Released: 11-Apr-2023 6:00 AM EDT
توصل بحث إلى أن النساء المصابات بأورام متعددة في أحد الثديين قد لا يضطررن إلى استئصاله.
Mayo Clinic

قد تتمكن النساء المصابات بأورام متعددة في أحد الثديين من تجنب استئصاله إذا أمكن استئصال هذه الأورام مع الاحتفاظ بأنسجة ثدي كافية، وذلك وفقًا لبحث قاده التحالف الطبي للتجارب السريرية في علم الأورام ومركز مايو كلينك الشامل للسرطان.

Released: 11-Apr-2023 6:00 AM EDT
Una investigación indica que las pacientes con varios tumores en una sola mama podrían no necesitar una mastectomía
Mayo Clinic

De acuerdo con la investigación dirigida por la Alianza para Ensayos Clínicos en Oncología y el Centro Oncológico Integral de Mayo Clinic, las pacientes que tengan varios tumores en una sola mama podrían evitar una mastectomía si los tumores se pueden extraer dejando bastante tejido mamario.

Newswise: Combination therapy overcomes BET inhibitor resistance
Released: 10-Apr-2023 5:05 PM EDT
Combination therapy overcomes BET inhibitor resistance
St. Jude Children's Research Hospital

St. Jude Children’s Research Hospital scientists developed a combination therapy for a leukemia subtype harboring rearrangements in the KMT2A gene. The approach overcomes the cancer’s drug resistance, without adding toxicity. The study appears in Proceedings of the National Academy of Science.

Released: 10-Apr-2023 4:35 PM EDT
Identifying cancer genes’ multiple personalities
Cold Spring Harbor Laboratory

Mutations in our genes can lead to severe problems, like colon or liver cancer. But cancer is very complex. Mutations in the same genes can lead to different subtypes of tumors in different people. Currently, scientists don’t have a good way to produce such tumor subtypes for study in the lab.

Released: 10-Apr-2023 3:15 PM EDT
Prior treatments influence immunotherapy response in advanced melanoma
University of California, Los Angeles (UCLA), Health Sciences

Research led by scientists at UCLA Jonsson Comprehensive Cancer Center found that responses to a type of immunotherapy called PD-1 checkpoint blockade in patients with advanced melanoma depended on whether or not they had previously received another immunotherapy – CTLA-4 blockade – as well as other factors.

Newswise: Scientists Enhance New Neurons to Restore Memory, Elevate Mood in Alzheimer’s Disease Research Model
Released: 10-Apr-2023 1:45 PM EDT
Scientists Enhance New Neurons to Restore Memory, Elevate Mood in Alzheimer’s Disease Research Model
University of North Carolina School of Medicine

UNC School of Medicine scientists demonstrated that stimulating a brain region called Supramammilary nucleus (SuM) located in the hypothalamus effectively enhanced adult-born neurons in the otherwise impaired Alzheimer’s brains of mice.

Released: 10-Apr-2023 12:35 PM EDT
Penn Medicine Study Reveals New Insights on Brain Development Sequence Through Adolescence
Perelman School of Medicine at the University of Pennsylvania

Brain development follows a newly identified, non-uniform developmental sequence rendering youth to environmental impacts through adolescence.

Released: 10-Apr-2023 8:05 AM EDT
University of Michigan receives $71M NIH grant to advance clinical & translational science
Michigan Medicine - University of Michigan

University of Michigan receives $71M NIH grant to advance clinical & translational science

Released: 7-Apr-2023 4:45 PM EDT
Novel approach prevents liver damage in animal models of Alagille syndrome
Baylor College of Medicine

Alagille syndrome, a genetic disease estimated to affect 1 in 30,000 individuals, is caused by mutations in the gene JAG1 in most cases. The mutations affect multiple organs including the liver where it often results in cholestasis, a condition in which the flow of bile from the liver stops or slows, leading to bile buildup that in time causes liver damage.

   
Released: 7-Apr-2023 2:20 PM EDT
Study reveals epigenetic vulnerability of acute myeloid leukemia
Baylor College of Medicine

Acute myeloid leukemia (AML) is an aggressive blood cancer that causes uncontrolled accumulation of white blood cells. Because of the poor outcomes of this disease, researchers across the globe have been on the hunt for new ways to treat AML, while preserving normal blood development.

3-Apr-2023 3:30 PM EDT
CHOP-led Study Identifies Two Different Regulatory T Cell Populations
Children's Hospital of Philadelphia

A regulatory class of human T cells descends from two different origins, one that relates to autoimmunity and one that relates to protective immunity, according to a new study led by Children’s Hospital of Philadelphia (CHOP). The findings, published today in Science Immunology, could pave the way for new treatments for autoimmune diseases that target the immune system selectively.

Released: 7-Apr-2023 1:10 PM EDT
New genetic finding provides clue for personalizing depression treatment
Medical University of South Carolina

A team of scientists at the Medical University of South Carolina (MUSC) has identified a stress-regulated gene that plays a role in the link between long-term stress and a common type of depressive behavior in mice.

   
Newswise: Activating adult-born neurons through deep brain stimulation alleviates Alzheimer’s symptoms in rodent models
Released: 6-Apr-2023 6:20 PM EDT
Activating adult-born neurons through deep brain stimulation alleviates Alzheimer’s symptoms in rodent models
Cell Press

People with Alzheimer’s disease develop defects in cognitive functions like memory as well as problems with noncognitive functions that can lead to anxiety and depression.

   
Newswise: UTEP to Investigate Pancreatic Cancer Risk Factors with $1M NIH Grant
Released: 6-Apr-2023 4:55 PM EDT
UTEP to Investigate Pancreatic Cancer Risk Factors with $1M NIH Grant
University of Texas at El Paso

The University of Texas at El Paso will undertake potentially transformative research on how specific risk factors promote pancreatic cancer development with support from a $1 million grant from the National Institutes of Health’s National Cancer Institute.

Released: 6-Apr-2023 1:20 PM EDT
Optimizing sepsis treatment timing with a machine learning model
Ohio State University

A new machine learning model that estimates optimal treatment timing for sepsis could pave the way for support tools that help physicians personalize treatment decisions at the patient bedside, researchers say.

   
5-Apr-2023 6:05 AM EDT
Men and women have different obesity drivers, pointing to the need for tailored interventions
University of California, Los Angeles (UCLA), Health Sciences

A new study from UCLA researchers finds sex-specific brain signals that appear to confirm that different drivers lead men and women to develop obesity.



close
1.62162